Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.02.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma

Turkish Journal of Medical Sciences
Medicine
2019English

Phase I Dose-Escalation Study of Venetoclax Plus Beam Followed by Autologous Stem Cell Transplant (Asct) for Chemoresistant, Relapsed/Refractory, or High-Risk Non-Hodgkin's Lymphoma (Nhl); Preliminary Results

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Autologous Stem Cell Transplantation for Hodgkin's Disease: Busulfan, Melphalan and Thiotepa Compared to a Radiation-Based Regimen

Bone Marrow Transplantation
TransplantationHematology
2003English

LACE-conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: Treatment Outcome and Risk Factor Analysis in 67 Patients From a Single Centre

Bone Marrow Transplantation
TransplantationHematology
2006English

Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin's Lymphoma: An Open-Label Phase 1 Trial

The Lancet
Medicine
2015English

High Dose Melphalan, BCNU and Etoposide With Autologous Bone Marrow Transplantation for Hodgkin's Disease

British Journal of Cancer
Cancer ResearchOncology
1989English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy